Names | |
---|---|
IUPAC name
dicopper 2-acetyloxybenzoate
| |
Other names
tetrakis-μ-acetylsalicylato-dicopper(II),
copper(II) aspirinate, cupric acetylsalicylate, cupric aspirinate, cupric aspirin complex | |
Identifiers | |
3D model (JSmol)
|
|
ChemSpider | |
ECHA InfoCard | 100.041.622 |
PubChem CID
|
|
CompTox Dashboard (EPA)
|
|
| |
| |
Properties | |
C36H28Cu2O16 | |
Molar mass | 843.69g/mol |
Appearance | Bright blue crystalline solid. |
Melting point | 248 to 255 °C (478 to 491 °F; 521 to 528 K) (decomposes) |
Pharmacology | |
Pharmacokinetics: | |
8.67 h (Human)[Ref#2] | |
Hazards | |
NIOSH (US health exposure limits): | |
PEL (Permissible)
|
TWA 1 mg/m3 (as Cu)[1] |
REL (Recommended)
|
TWA 1 mg/m3 (as Cu)[1] |
IDLH (Immediate danger)
|
TWA 100 mg/m3 (as Cu)[1] |
Related compounds | |
Other cations
|
Zinc aspirinate, Aluminium aspirinate |
Related compounds
|
Aspirin |
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
|
Copper(II) aspirinate is an aspirin chelate of copper(II) cations (Cu2+). It is used to treat rheumatoid arthritis.